The Chairman and CEO of DNA Electronics, a provider of point-of-care genomic diagnostics solutions for medical and healthcare applications, Chris Toumazou, has been awarded the European Inventor Award 2014 in the Research category, for his rapid USB-based DNA testing device.
Announced at the European Inventor Awards ceremony in Berlin on June 17th 2014, Toumazou’s win recognises his contribution to medical research with his ground-breaking invention. The device, which can show the results of a DNA test within minutes, uses silicon transistors to identify DNA and RNA, offering a simpler, cheaper and more discrete alternative to existing DNA analysis equipment.
The invention involves the amplification and detection of DNA and other biomolecules using pH measurement, providing the ground work for DNA Electronics’ molecular diagnostics platform Genalysis®. With the capability of identifying genomic sequences, not only in patients, but also in infectious agents, the company is developing products that will provide clinicians with rapid actionable diagnosis of life-threatening conditions.
DNA Electronics is a developer of semiconductor solutions for real-time nucleic acid detection which enables faster, simpler and more cost-effective DNA analysis platforms.
A spin-out of Imperial College London, DNA Electronics was founded by Professor Toumazou following his invention of the company’s core technology that allows CMOS transistors to be switched on and off with DNA – the key invention enabling semiconductor-based sequencing. Prof. Toumazou’s innovation has culminated in the world’s first DNA logic on standard CMOS technology.
The company’s IP portfolio includes techniques for monitoring nucleotide insertions using ion-sensitive transistors, enabling label-free electronic DNA sequencing and diagnostics platforms. DNA Electronics (DNAe) has developed the ground-breaking Genalysis® platform of disposable silicon chip-based solutions for real-time nucleic acid sequence detection at the point of care, providing end users with technology as yet unavailable outside a laboratory.
DNA Electronics has a non-exclusive, field-limited licensing agreement with Ion Torrent (now part of Thermo Fisher Scientific), whose next generation sequencing technology is based on DNA Electronics’ semiconductor sequencing IP. DNA Electronics has also licensed its Genalysis® technology platform to GENEU™, a company that is delivering on-the-spot genetic analytics services for cosmetics and skincare applications.
For more information: http://www.dnae.co.uk